Director Springer Reports a $4.2 Million RNAC Purchase

October 7, 2024

The most notable insider activity on today's list comes via a Form 4 filing by Cartesian Therapeutics Inc $RNAC director Timothy A. Springer.

Springer reported a $4.2 million purchase of RNAC shares.

Neuberger Berman Group LLC filed a 13G for CNX Resources Corporation $CNX, revealing an initial stake of 5.03%.

Here’s The Hot Corner, with data from October 4, 2024:

The chairman and CEO of ARMOUR Residential REIT $ARR revealed a purchase of $198,570 in the real estate company.

Performance marketing platform and recent IPO Ibotta Inc $IBTA saw a $1.1 million Form 4 filing from D.E. Shaw & Co.

After breaking out of a multi-year base in 2023, CNX has been accelerating to the upside, making a series of higher highs and higher lows since:

We see no reason why CNX shouldn’t hit more price targets in the future.

As long as we’re above 27, the bias is higher. The stock is a leader in the energy sector.

Stay tuned. We'll be back on Tuesday with more insider activity.

For questions about your membership, contact us at 323-421-7910 or info@stockmarketmedia.com

Filed Under: